Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Discordant diagnostic criteria for pneumonia in COPD trials: a review

Journal article

Wise RA. et al, (2021), European Respiratory Review, 30, 210124 - 210124

Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population

Journal article

Ashdown HF. et al, (2021), ERJ Open Research, 00606 - 2021

Improved COVID-19 outcomes in a large non-invasive respiratory support cohort despite emergence of the alpha variant

Journal article

Turnbull CD. et al, (2021), BMJ Open Respiratory Research, 8, e001044 - e001044

Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals

Journal article

Singh D. et al, (2021), International Journal of Chronic Obstructive Pulmonary Disease, Volume 16, 3009 - 3016

Renaming COPD exacerbations: the UK respiratory nursing perspective.

Journal article

Mwasuku C. et al, (2021), BMC pulmonary medicine, 21

Predicting treatment outcomes following an exacerbation of airways disease

Journal article

Halner A. et al, (2021), PLOS ONE, 16, e0254425 - e0254425

Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?

Journal article

Ramakrishnan S. and Bafadhel M., (2021), Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 127

Research priorities for exacerbations of COPD.

Journal article

Alqahtani JS. et al, (2021), The Lancet. Respiratory medicine, 9, 824 - 826

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

Journal article

Ramakrishnan S. et al, (2021), LANCET RESPIRATORY MEDICINE, 9, 763 - 772

Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO

Journal article

Pavord I. et al, (2021), International Journal of Chronic Obstructive Pulmonary Disease, Volume 16, 1755 - 1770

Inhaled budesonide for early treatment of COVID-19 - Authors' reply.

Journal article

Ramakrishnan S. and Bafadhel M., (2021), The Lancet. Respiratory medicine

Accuracy of the Albus Home Research Device (RD) for the Non-Contact and Passive Monitoring of Nocturnal Respiratory Rate at Home in an Adult Population

Conference paper

Do WI. et al, (2021), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 203

Antimicrobial Peptides SLPI and Beta Defensin-1 in Sputum are Negatively Correlated with FEV1

Journal article

Cane JL. et al, (2021), International Journal of Chronic Obstructive Pulmonary Disease, Volume 16, 1437 - 1447

Pediatric Nocturnal Respiratory Rate Monitoring Using a Non-Contact and Passive Bedside Device: Accuracy of the Albus Home Research Device (RD)

Conference paper

Wheeler CJ. et al, (2021), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 203

A Comprehensive Analysis of the Stability of Blood Eosinophil Levels

Journal article

Chipps BE. et al, (2021), Annals of the American Thoracic Society

Load More